| Financial Year |
March 31 2023 |
| Monetary Funds |
57,944,674,000.00 |
| Held-for-trading Financial Assets |
12,319,421,000.00 |
| Notes Receivable |
513,857,000.00 |
| Accounts Receivable |
7,710,105,000.00 |
| Advances to Suppliers |
4,227,578,000.00 |
| Other Receivables |
3,012,893,000.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
46,820,830,000.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,878,449,000.00 |
| Total Current Assets |
136,889,938,000.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,946,445,000.00 |
| Investment Properties |
574,709,000.00 |
| Fixed Assetes |
36,774,430,000.00 |
| Under-construction Projects |
10,206,653,000.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
14,772,028,000.00 |
| R&D expenses |
-- |
| Goodwill |
5,987,688,000.00 |
| Long-Term Deferred and Prepaid Expenses |
234,896,000.00 |
| Deferred Income Tax Assets |
1,466,799,000.00 |
| Other Non-Current Assets |
20,571,227,000.00 |
| Sub-Total of Non-Current Assets |
94,741,977,000.00 |
| Total Assets |
231,631,915,000.00 |
| Short-Term Loans |
95,234,220,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,714,969,000.00 |
| Accounts Payable |
6,538,773,000.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
659,775,000.00 |
| Taxes Payable |
818,521,000.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,058,691,000.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,980,608,000.00 |
| Other Current Liabilities |
2,284,980,000.00 |
| Sub-Total of Current Liabilities |
117,904,374,000.00 |
| Long-term Loans |
16,946,514,000.00 |
| Bonds Payable |
504,563,000.00 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
6,313,000.00 |
| Deferred Income Tax Liabilities |
760,873,000.00 |
| Other Non-Current Liabilities |
236,391,000.00 |
| Sub-Total of Non-Current Liabilities |
19,460,369,000.00 |
| Total Liabilities |
137,364,743,000.00 |
| Paid-In Capital(Or Share Stock) |
5,421,592,000.00 |
| Capital Surplus |
36,708,444,000.00 |
| Surplus Reserve |
2,133,759,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
45,460,587,000.00 |
| Minority Stockholder's Interest |
4,492,131,000.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
89,775,041,000.00 |
| Owner's Equity（Stockholder's Equity） |
94,267,172,000.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
231,631,915,000.00 |
